Skip to product information
1 of 6

GHK-Cu Copper Peptide Tablets

GHK-Cu Copper Peptide Tablets

Read reviews →
Also see: Amazon · Google · Reddit
Regular price $38.00 USD
Regular price $40.00 USD Sale price $38.00 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

46/100
Rejected

Six-dimension breakdown

Evidence
30
Formulation
55
Manufacturing
60
Safety
55
Transparency
58
Sustainability
45

Why this scored 46/100

Neurogan Health GHK-Cu Copper Peptide Tablets deliver 2 mg of the tripeptide glycyl-histidyl-lysine chelated with copper per serving, marketed as an oral supplement for skin health. The core problem is mechanistic, not brand-related. GHK-Cu is a real molecule with a real evidence base — but exclusively for topical application. Every clinical study showing skin-remodeling, hair-growth, or wound-healing effects (Pickart 2015 reviews; Zhou 2020) used GHK-Cu delivered topically as a cream or serum, or intradermally via microneedling. Oral GHK-Cu is a peptide that will be enzymatically hydrolyzed to its constituent amino acids in the stomach and small intestine; no published human PK data shows intact GHK-Cu reaching skin capillaries from an oral tablet. Adding elemental copper (2 mg) does contribute to daily copper intake (RDA ~900 μg), but that is a mineral effect, not a peptide effect. Rejected — the product mechanism as marketed is not supported by human data, and the 'first of its kind' framing masks that fact.

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
46 / 100
Tier
Rejected
Category
Supplements
Subcategory
skin hair beauty
Last scored
Third-party certifications
None on record at time of scoring
Vendor
Neurogan Health
Tags
Neurogan Health, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details